சம்மன்கள் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சம்மன்கள் புற்றுநோய் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சம்மன்கள் புற்றுநோய் மையம் Today - Breaking & Trending Today

BMS drug Opdivo lands FDA approval for gastro cancers


BMS drug Opdivo lands FDA approval for gastro cancers
By Jenni Spinner
The therapeutic has been approved as an adjuvant treatment for varieties of esophageal cancers in patients who have received neoadjuvant chemoradiotherapy.
Bristol Myers Squibb (BMS) announced the US Food and Drug Administration (FDAP has approved Opdivo (nivolumab, injection for intravenous use) for adjuvant treatment of completely resected esophageal or gastroesophageal junction (GEJ) cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT). The approval is based upon results from the recent Phase III CheckMate -577 trial, which evaluated the drug in comparison to placebo in esophageal or GEJ cancer patients with residual pathologic disease following neoadjuvant CRT and complete resection. ....

Ronan Kelly , Baylor Scott , Ww Caruth Jr , Bristol Myers Squibb , Adam Lenkowsky , Baylor University Medical Center , White Charlesa Sammons Cancer Center , Drug Administration , White Charles , Sammons Cancer Center , Endowed Chair , Time Oncology Review , Project Orbis , Markets Amp Regulations , Clinical Development , Linical Evolution , Phase Iii Iv , Regulatory Affairs , Bristol Myers Squibb , ரோனன் கெல்லி , பேலர் ஸ்காட் , வ்வ் கருத் ஜூனியர் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , பேலர் பல்கலைக்கழகம் மருத்துவ மையம் , வெள்ளை சார்லஸ் , சம்மன்கள் புற்றுநோய் மையம் ,